Minerva Neurosciences, Inc. (NERV)Healthcare | Biotechnology | Burlington, United States | NasdaqCM
6.89 USD
+0.16
(2.377%)
⇧
(April 20, 2026, 4 p.m.
EDT)
Short-term: ★★★★☆ | Long-term: ★★★★★ | Dividends: ☆☆☆☆☆ |
Hot Take | April 19, 2026, 12:22 a.m. EDT
While recent volatility masked a strong bullish trend over 14 days leading to a +14% close, Minerva Neurosciences presents an exceptional 5-year strategic opportunity driven by the roluperidone development pipeline and a robust $290M market cap supported by strong analyst pricing targets ($9.50 mean vs current $6.73), despite the absence of dividend income and negative earnings. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.293508 |
| AutoARIMA | 0.315857 |
| AutoETS | 0.315861 |
| MSTL | 0.316411 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 55% |
| H-stat | 2.71 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.370 |
| Excess Kurtosis | -0.78 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Market Cap | 298,160,608 |
| Forward P/E | -14.35 |
| Beta | -0.21 |
| Website | https://www.minervaneurosciences.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 3.0292397 |
| Address1 | 1,500 District Avenue |
| All Time High | 126.72 |
| All Time Low | 1.15 |
| Ask | 8.44 |
| Ask Size | 2 |
| Average Analyst Rating | 2.7 - Hold |
| Average Daily Volume10 Day | 242,000 |
| Average Daily Volume3 Month | 247,567 |
| Average Volume | 247,567 |
| Average Volume10Days | 242,000 |
| Beta | -0.207 |
| Bid | 4.98 |
| Bid Size | 2 |
| Book Value | -3.252 |
| City | Burlington |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 6.89 |
| Current Ratio | 36.28 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 6.95 |
| Day Low | 6.53 |
| Display Name | Minerva Neurosciences |
| Earnings Timestamp End | 1,754,397,000 |
| Earnings Timestamp Start | 1,754,397,000 |
| Ebitda | -15,097,528 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -18.6 |
| Enterprise Value | 280,820,704 |
| Eps Current Year | -0.6 |
| Eps Forward | -0.48 |
| Eps Trailing Twelve Months | -34.67 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 6.4423 |
| Fifty Day Average Change | 0.44770002 |
| Fifty Day Average Change Percent | 0.06949382 |
| Fifty Two Week Change Percent | 302.92395 |
| Fifty Two Week High | 12.46 |
| Fifty Two Week High Change | -5.57 |
| Fifty Two Week High Change Percent | -0.4470305 |
| Fifty Two Week Low | 1.3 |
| Fifty Two Week Low Change | 5.59 |
| Fifty Two Week Low Change Percent | 4.3 |
| Fifty Two Week Range | 1.3 - 12.46 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,404,221,400,000 |
| Float Shares | 24,857,247 |
| Forward Eps | -0.48 |
| Forward P E | -14.354167 |
| Free Cashflow | -8,543,694 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 7 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Gross Profits | -5,759,473 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.03597 |
| Held Percent Institutions | 0.6829 |
| Implied Shares Outstanding | 43,274,399 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,655,769,600 |
| Last Split Factor | 1:8 |
| Long Business Summary | Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone, which is in Phase 3 confirmatory trial for the treatment of negative symptoms in patients with schizophrenia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts. |
| Long Name | Minerva Neurosciences, Inc. |
| Market | us_market |
| Market Cap | 298,160,608 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_261133065 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -293,423,168 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 299,285,736 |
| Number Of Analyst Opinions | 3 |
| Open | 6.68 |
| Operating Cashflow | -13,510,936 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 617 600 7373 |
| Previous Close | 6.73 |
| Price Eps Current Year | -11.483333 |
| Price Hint | 2 |
| Price To Book | -2.118696 |
| Profit Margins | 0.0 |
| Quick Ratio | 35.932 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | hold |
| Recommendation Mean | 2.66667 |
| Region | US |
| Regular Market Change | 0.16 |
| Regular Market Change Percent | 2.37741 |
| Regular Market Day High | 6.95 |
| Regular Market Day Low | 6.53 |
| Regular Market Day Range | 6.53 - 6.95 |
| Regular Market Open | 6.68 |
| Regular Market Previous Close | 6.73 |
| Regular Market Price | 6.89 |
| Regular Market Time | 1,776,715,200 |
| Regular Market Volume | 242,551 |
| Return On Assets | -0.13972999 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 43,274,398 |
| Shares Percent Shares Out | 0.023599999 |
| Shares Short | 1,020,925 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 437,962 |
| Short Name | Minerva Neurosciences, Inc |
| Short Percent Of Float | 0.0252 |
| Short Ratio | 2.41 |
| Source Interval | 15 |
| State | MA |
| Symbol | NERV |
| Target High Price | 14.0 |
| Target Low Price | 7.0 |
| Target Mean Price | 9.5 |
| Target Median Price | 7.5 |
| Total Cash | 82,301,816 |
| Total Cash Per Share | 1.902 |
| Total Debt | 60,000,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -34.67 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 3.954245 |
| Two Hundred Day Average Change | 2.9357548 |
| Two Hundred Day Average Change Percent | 0.74243116 |
| Type Disp | Equity |
| Volume | 242,551 |
| Website | https://www.minervaneurosciences.com |
| Zip | 1,803 |